Ameriprise’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-107,192
| Closed | -$814K | – | 4086 |
|
|
2025
Q3 | $814K | Hold |
107,192
| – | – | ﹤0.01% | 3454 |
|
|
2025
Q2 | $960K | Sell |
107,192
-1,640,114
| -94% | -$15.3M | ﹤0.01% | 3282 |
|
|
2025
Q1 | $13.1M | Buy |
1,747,306
+26,725
| +2% | +$216K | ﹤0.01% | 1576 |
|
|
2024
Q4 | $12.9M | Sell |
1,720,581
-51,920
| -3% | -$394K | ﹤0.01% | 1619 |
|
|
2024
Q3 | $13.5M | Sell |
1,772,501
-93,122
| -5% | -$708K | ﹤0.01% | 1569 |
|
|
2024
Q2 | $11.5M | Sell |
1,865,623
-469,568
| -20% | -$2.59M | ﹤0.01% | 1623 |
|
|
2024
Q1 | $11.9M | Buy |
2,335,191
+1,122,212
| +93% | +$6.31M | ﹤0.01% | 1647 |
|
|
2023
Q4 | $7.27M | Buy |
1,212,979
+563,066
| +87% | +$3.26M | ﹤0.01% | 2055 |
|
|
2023
Q3 | $4.6M | Buy |
649,913
+6,876
| +1% | +$49.4K | ﹤0.01% | 2342 |
|
|
2023
Q2 | $4.53M | Buy |
643,037
+308,648
| +92% | +$2.48M | ﹤0.01% | 2420 |
|
|
2023
Q1 | $2.79M | Sell |
334,389
-497,936
| -60% | -$4.79M | ﹤0.01% | 2681 |
|
|
2022
Q4 | $9.55M | Buy |
832,325
+313,623
| +60% | +$3.91M | ﹤0.01% | 1773 |
|
|
2022
Q3 | $6.54M | Buy |
518,702
+270,419
| +109% | +$3.48M | ﹤0.01% | 2028 |
|
|
2022
Q2 | $2.63M | Buy |
248,283
+114,055
| +85% | +$1.18M | ﹤0.01% | 2705 |
|
|
2022
Q1 | $2.18M | Buy |
+134,228
| New | +$2.15M | ﹤0.01% | 2872 |
|
|
2021
Q3 | – | Sell |
-47,483
| Closed | -$751K | – | 3855 |
|
|
2021
Q2 | $751K | Sell |
47,483
-2,851
| -6% | -$38.7K | ﹤0.01% | 3322 |
|
|
2021
Q1 | $512K | Sell |
50,334
-20,240
| -29% | -$209K | ﹤0.01% | 3394 |
|
|
2020
Q4 | $525K | Buy |
70,574
+19,950
| +39% | +$103K | ﹤0.01% | 3327 |
|
|
2020
Q3 | $174K | Sell |
50,624
-29,342
| -37% | -$126K | ﹤0.01% | 3566 |
|
|
2020
Q2 | $381K | Buy |
+79,966
| New | +$319K | ﹤0.01% | 3286 |
|
|
2020
Q1 | – | Sell |
-109,019
| Closed | -$377K | – | 3643 |
|
|
2019
Q4 | $377K | Buy |
109,019
+21,769
| +25% | +$54.8K | ﹤0.01% | 3424 |
|
|
2019
Q3 | $250K | Buy |
+87,250
| New | +$271K | ﹤0.01% | 3497 |
|
|
2019
Q1 | – | Sell |
-118,223
| Closed | -$954K | – | 3696 |
|
|
2018
Q4 | $954K | Buy |
+118,223
| New | +$919K | ﹤0.01% | 2958 |
|
|
2014
Q3 | – | Sell |
-30
| Closed | – | – | 5808 |
|
|
2014
Q2 | $0 | Buy |
+30
| New | +$292 | ﹤0.01% | 5589 |
|
|
2013
Q4 | – | Sell |
-3,000
| Closed | -$22K | – | 5151 |
|
|
2013
Q3 | $22K | Buy |
+3,000
| New | +$15.2K | ﹤0.01% | 4344 |
|
Other funds holding BCRX
RCM
DM
KCM
